Synlogic Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -23.27. In total, the insiders bought 535.54K and sold 350.42K SYBX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-23.27
Buy 535.54K shares
Sell 350.42K shares
53% Buy Activity
Weak Positive Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Oct 29, 2025
Sell
Common Stock
S-Sale
Dooley Mary Beth
See Remarks Below
Officer 157
Value: $284
Apr 26, 2025
Buy
Common Stock
A-Award
Shea Richard P
Director
Director 15 000
Value: $9K
Apr 26, 2025
Buy
Common Stock
A-Award
Flynn James P
Director
Director 15 000
Value: $9K
Apr 26, 2025
Buy
Common Stock
A-Award
Flynn James P
Director
Director 15 000
Value: $9K
Apr 26, 2025
Buy
Common Stock
A-Award
Shea Richard P
Director
Director 15 000
Value: $9K
Apr 02, 2025
Sell
Common Stock
S-Sale
Dooley Mary Beth
See Remarks Below
Officer 144
Value: $173
Apr 02, 2025
Sell
Common Stock
S-Sale
Dooley Mary Beth
See Remarks Below
Officer 144
Value: $173
Feb 03, 2025
Sell
Common Stock
S-Sale
Dooley Mary Beth
See Remarks Below
Officer 2 107
Value: $3K
Feb 03, 2025
Sell
Common Stock
S-Sale
Dooley Mary Beth
See Remarks Below
Officer 2 107
Value: $3K
Oct 29, 2024
Sell
Common Stock
S-Sale
Dooley Mary Beth
Head Of Finance
Officer 79
Value: $111
Oct 29, 2024
Sell
Common Stock
S-Sale
Dooley Mary Beth
Head Of Finance
Officer 79
Value: $111
Apr 02, 2024
Sell
Common Stock
S-Sale
Dooley Mary Beth
Head Of Finance
Officer 188
Value: $325
Apr 02, 2024
Sell
Common Stock
S-Sale
Awad Antoine
Chief Operating Officer
C-Suite Officer 372
Value: $644
Apr 02, 2024
Sell
Common Stock
S-Sale
Awad Antoine
Chief Operating Officer
C-Suite Officer 372
Value: $644
Apr 02, 2024
Sell
Common Stock
S-Sale
Dooley Mary Beth
Head Of Finance
Officer 188
Value: $325
Mar 19, 2024
Buy
Stock Option (right to buy)
A-Award
Flynn James P
Director
Director 4 000
Value: $7K
Mar 19, 2024
Buy
Common Stock
J-Other
Flynn James P
Insider
Other 0
Value: $0
Mar 19, 2024
Buy
Common Stock
J-Other
Flynn James P
Insider
Other 0
Value: $0
Mar 19, 2024
Buy
Stock Option (right to buy)
A-Award
Flynn James P
Director
Director 4 000
Value: $7K
Mar 18, 2024
Buy
Common Stock
Dooley Mary Beth
Head Of Finance
Officer 0
Value: $0
Mar 18, 2024
Buy
Stock Option (right to buy)
Dooley Mary Beth
Head Of Finance
Officer 3 612
Value: $7K
Mar 18, 2024
Buy
Stock Option (right to buy)
Dooley Mary Beth
Head Of Finance
Officer 3 612
Value: $7K
Mar 18, 2024
Buy
Common Stock
Dooley Mary Beth
Head Of Finance
Officer 0
Value: $0
Feb 09, 2024
Buy
Common stock
Funicular Funds, Lp
10 Percent Owner
10% Owner 0
Value: $0
Feb 09, 2024
Buy
Common stock
Funicular Funds, Lp
10 Percent Owner
10% Owner 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT SYNLOGIC INC
Synlogic
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase II clinical trials to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE